Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions

F1000Research

Volumn 6, Issue , 2017, Pages

  Saas, Philippe ^a   Varin, Alexis ^a   Perruche, Sylvain ^a   Ceroi, Adam ^a,b  

^a UNIVERSITÉ BOURGOGNE FRANCHE COMTÉ   (France)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cholesterol; Fatty acid; Glycolysis; Immunometabolism; LXR; Plasmacytoid dendritic cells; PPAR; Type I interferon

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INFLUENZA VACCINE; INTERFERON; INTERLEUKIN 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNE DISEASE; CELL MIGRATION; CELLULAR DISTRIBUTION; CHOLESTEROL METABOLISM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GLYCOLYSIS; HUMAN; INFLUENZA VIRUS; INNATE IMMUNITY; LIPID METABOLISM; LIPOGENESIS; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW; RHINOVIRUS; UPREGULATION;

EID: 85019568379     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.11332.1     Document Type: Review

References (105)

1. O'Neill LA Pearce EJ: Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 2016;213(1):15-23. 26694970 10.1084/jem.20151570 4710204
2. O'Neill LA Kishton RJ Rathmell J: A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553-565. 27396447 10.1038/nri.2016.70 5001910
3. Pearce EJ Everts B: Dendritic cell metabolism. Nat Rev Immunol. 2015;15(1):18-29. 25534620 10.1038/nri3771 4495583
4. Bajwa G DeBerardinis RJ Shao B: Cutting Edge: Critical Role of Glycolysis in Human Plasmacytoid Dendritic Cell Antiviral Responses. J Immunol. 2016;196(5):2004-2009. 26826244 10.4049/jimmunol.1501557 4761472
5. Wu D Sanin DE Everts B: Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function. Immunity. 2016;44(6):1325-1336. 27332732 10.1016/j.immuni.2016.06.006
6. Ceroi A Delettre FA Marotel C: The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation. Haematologica. 2016;101(3):e72-76. 26635040 10.3324/haematol.2015.135459 4815731
7. Swiecki M Colonna M: The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 2015;15(8):471-485. 26160613 10.1038/nri3865 4808588
8. Weichhart T Hengstschläger M Linke M: Regulation of innate immune cell function by mTOR. Nat Rev Immunol. 2015;15(10):599-614. 26403194 10.1038/nri3901
9. Sharma MD Hou DY Liu Y: Indoleamine 2,3-dioxygenase controls conversion of Foxp3 + Tregs to TH17-like cells in tumor-draining lymph nodes. Blood. 2009;113(24):6102-6111. 19366986 10.1182/blood-2008-12-195354 2699232
10. Pearce EL Pearce EJ: Metabolic pathways in immune cell activation and quiescence. Immunity. 2013;38(4):633-643. 23601682 10.1016/j.immuni.2013.04.005 3654249
11. Audano M Ferrari A Fiorino E: Energizing Genetics and Epi-genetics: Role in the Regulation of Mitochondrial Function. Curr Genomics. 2014;15(6):436-456. 25646072 10.2174/138920291506150106151119 4311388
12. Li W Sivakumar R Titov AA: Metabolic Factors that Contribute to Lupus Pathogenesis. Crit Rev Immunol. 2016;36(1):75-98. 27480903 10.1615/CritRevImmunol.2016017164 5278665
13. Guilliams M Ginhoux F Jakubzick C: Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol. 2014;14(8):571-578. 25033907 10.1038/nri3712 4638219
14. Cella M Jarrossay D Facchetti F: Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999;5(8):919-923. 10426316 10.1038/11360
15. Siegal FP Kadowaki N Shodell M: The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999;284(5421):1835-1837. 10364556 10.1126/science.284.5421.1835
16. Asselin-Paturel C Boonstra A Dalod M: Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol. 2001;2(12):1144-1150. 11713464 10.1038/ni736
17. Nakano H Yanagita M Gunn MD: CD11c +B220 +Gr-1 + cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med. 2001;194(8):1171-1178. 11602645 10.1084/jem.194.8.1171 2193516
18. Ferrero I Held W Wilson A: Mouse CD11c + B220 + Gr1 + plasmacytoid dendritic cells develop independently of the T-cell lineage. Blood. 2002;100(8):2852-2857. 12351395 10.1182/blood-2002-01-0214
19. Martin P Del Hoyo GM Anjuere F: Characterization of a new subpopulation of mouse CD8α + B220 + dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood. 2002;100(2):383-390. 12091326 10.1182/blood.V100.2.383
20. Robbins SH Walzer T Dembélé D: Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 2008;9(1):R17. 18218067 10.1186/gb-2008-9-1-r17 2395256
21. Liu K Victora GD Schwickert TA: In vivo analysis of dendritic cell development and homeostasis. Science. 2009;324(5925):392-397. 19286519 10.1126/science.1170540 2803315
22. Li HS Gelbard A Martinez GJ: Cell-intrinsic role for IFN-α-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response. Blood. 2011;118(14):3879-3889. 21828128 10.1182/blood-2011-04-349761 3193265
23. Sisirak V Vey N Vanbervliet B: CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues. Blood. 2011;118(19):5130-5140. 21937703 10.1182/blood-2010-07-295626 3217401
24. de Heer HJ Hammad H Soullié T: Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med. 2004;200(1):89-98. 15238608 10.1084/jem.20040035 2213319
25. Tokita D Sumpter TL Raimondi G: Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cells. J Hepatol. 2008;49(6):1008-1018. 18926588 10.1016/j.jhep.2008.07.028 2631180
26. Matta BM Castellaneta A Thomson AW: Tolerogenic plasmacytoid DC. Eur J Immunol. 2010;40(10):2667-2676. 20821731 10.1002/eji.201040839 3974856
27. Okada T Lian ZX Naiki M: Murine thymic plasmacytoid dendritic cells. Eur J Immunol. 2003;33(4):1012-1019. 12672067 10.1002/eji.200323616
28. Li J Park J Foss D: Thymus-homing peripheral dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state thymus. J Exp Med. 2009;206(3):607-622. 19273629 10.1084/jem.20082232 2699131
29. Hadeiba H Lahl K Edalati A: Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. Immunity. 2012;36(3):438-450. 22444632 10.1016/j.immuni.2012.01.017 3315699
30. Vermi W Riboldi E Wittamer V: Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J Exp Med. 2005;201(4):509-515. 15728234 10.1084/jem.20041310 2213064
31. Gilliet M Cao W Liu YJ: Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol. 2008;8(8):594-606. 18641647 10.1038/nri2358
32. Reizis B Bunin A Ghosh HS: Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol. 2011;29:163-183. 21219184 10.1146/annurev-immunol-031210-101345 4160806
33. Cervantes-Barragan L Lewis KL Firner S: Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci U S A. 2012;109(8):3012-3017. 22315415 10.1073/pnas.1117359109 3286988
34. Swiecki M Gilfillan S Vermi W: Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8 + T cell accrual. Immunity. 2010;33(6):955-966. 21130004 10.1016/j.immuni.2010.11.020 3588567
35. Takagi H Fukaya T Eizumi K: Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo. Immunity. 2011;35(6):958-971. 22177923 10.1016/j.immuni.2011.10.014
36. Pelka K Latz E: IRF5, IRF8, and IRF7 in human pDCs - the good, the bad, and the insignificant? Eur J Immunol. 2013;43(7):1693-1697. 23828296 10.1002/eji.201343739
37. Kadowaki N Ho S Antonenko S: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med. 2001;194(6):863-869. 11561001 10.1084/jem.194.6.863 2195968
38. Diebold SS Kaisho T Hemmi H: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004;303(5663):1529-1531. 14976261 10.1126/science.1093616
39. Moynagh PN: TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol. 2005;26(9):469-476. 16006187 10.1016/j.it.2005.06.009
40. Barrat FJ Meeker T Gregorio J: Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med. 2005;202(8):1131-1139. 16230478 10.1084/jem.20050914 2213213
41. Lande R Gregorio J Facchinetti V: Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007;449(7162):564-569. 17873860 10.1038/nature06116
42. Ganguly D Chamilos G Lande R: Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med. 2009;206(9):1983-1994. 19703986 10.1084/jem.20090480 2737167
43. Honda K Yanai H Negishi H: IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature. 2005;434(7034):772-777. 15800576 10.1038/nature03464
44. Guiducci C Ghirelli C Marloie-Provost MA: PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation. J Exp Med. 2008;205(2):315-322. 18227218 10.1084/jem.20070763 2271003
45. Bauer M Redecke V Ellwart JW: Bacterial CpG-DNA triggers activation and maturation of human CD11c -, CD123 + dendritic cells. J Immunol. 2001;166(8):5000-5007. 11290780 10.4049/jimmunol.166.8.5000
46. Angelot F Seillès E Biichlé S: Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases. Haematologica. 2009;94(11):1502-1512. 19648164 10.3324/haematol.2009.010934 2770960
47. Piqueras B Connolly J Freitas H: Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood. 2006;107(7):2613-2618. 16317096 10.1182/blood-2005-07-2965 1895384
48. Kerkmann M Rothenfusser S Hornung V: Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol. 2003;170(9):4465-4474. 12707322 10.4049/jimmunol.170.9.4465
49. Tian J Avalos AM Mao SY: Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007;8(5):487-496. 17417641 10.1038/ni1457
50. Dumitriu IE Baruah P Bianchi ME: Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur J Immunol. 2005;35(7):2184-2190. 15915542 10.1002/eji.200526066
51. Rovere-Querini P Capobianco A Scaffidi P: HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004;5(8):825-830. 15272298 10.1038/sj.embor.7400205 1299116
52. Garcia-Romo GS Caielli S Vega B: Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med. 2011;3(73):73ra20. 21389264 10.1126/scitranslmed.3001201 3143837
53. Lande R Ganguly D Facchinetti V: Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med. 2011;3(73):73ra19. 21389263 10.1126/scitranslmed.3001180 3399524
54. Duffau P Seneschal J Nicco C: Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci Transl Med. 2010;2(47):47ra63. 20811042 10.1126/scitranslmed.3001001
55. Broz P Monack DM: Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol. 2013;13(8):551-565. 23846113 10.1038/nri3479
56. Bonnefoy F Perruche S Couturier M: Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation. J Immunol. 2011;186(10):5696-5705. 21460208 10.4049/jimmunol.1001523
57. Munn DH Sharma MD Hou D: Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest. 2004;114(2):280-290. 15254595 10.1172/JCI21583 449750
58. Sharma MD Baban B Chandler P: Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest. 2007;117(9):2570-2582. 17710230 10.1172/JCI31911 1940240
59. Mellor AL Baban B Chandler PR: Cutting edge: CpG oligonucleotides induce splenic CD19 + dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J Immunol. 2005;175(9):5601-5605. 16237046 10.4049/jimmunol.175.9.5601
60. Pallotta MT Orabona C Volpi C: Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol. 2011;12(9):870-878. 21804557 10.1038/ni.2077
61. Cao W Rosen DB Ito T: Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med. 2006;203(6):1399-1405. 16735691 10.1084/jem.20052454 2118323
62. Dzionek A Sohma Y Nagafune J: BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med. 2001;194(12):1823-1834. 11748283 10.1084/jem.194.12.1823 2193584
63. Saas P Perruche S: Functions of TGF-β-exposed plasmacytoid dendritic cells. Crit Rev Immunol. 2012;32(6):529-553. 23428227 10.1615/CritRevImmunol.2013005868
64. Grouard G Rissoan MC Filgueira L: The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med. 1997;185(6):1101-1111. 9091583 10.1084/jem.185.6.1101 2196227
65. Ghirelli C Zollinger R Soumelis V: Systematic cytokine receptor profiling reveals GM-CSF as a novel TLR-independent activator of human plasmacytoid predendritic cells. Blood. 2010;115(24):5037-5040. 20382843 10.1182/blood-2010-01-266932
66. Chistiakov DA Orekhov AN Sobenin IA: Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation. Front Physiol. 2014;5:279. 25120492 10.3389/fphys.2014.00279 4110479
67. Fritsch SD Weichhart T: Effects of Interferons and Viruses on Metabolism. Front Immunol. 2016;7:630. 28066439 10.3389/fimmu.2016.00630 5174094
68. Banchereau J Pascual V: Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006;25(3):383-392. 16979570 10.1016/j.immuni.2006.08.010
69. Diana J Simoni Y Furio L: Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med. 2013;19(1):65-73. 23242473 10.1038/nm.3042
70. van Bon L Affandi AJ Broen J: Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med. 2014;370(5):433-443. 24350901 10.1056/NEJMoa1114576 4040466
71. Nestle FO Conrad C Tun-Kyi A: Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med. 2005;202(1):135-143. 15998792 10.1084/jem.20050500 2212894
72. Millet A Martin KR Bonnefoy F: Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. J Clin Invest. 2015;125(11):4107-4121. 26436651 10.1172/JCI78182 4639994
73. Bossard C Malard F Arbez J: Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease. Leukemia. 2012;26(7):1471-1474. 22333879 10.1038/leu.2012.41
74. Malard F Bossard C Brissot E: Increased plasmacytoid dendritic cells and RORγt-expressing immune effectors in cutaneous acute graft-versus-host disease. J Leukoc Biol. 2013;94(6):1337-1343. 23990625 10.1189/jlb.0513295
75. Döring Y Zernecke A: Plasmacytoid dendritic cells in atherosclerosis. Front Physiol. 2012;3:230. 22754539 10.3389/fphys.2012.00230 3385355
76. Soumelis V Scott I Gheyas F: Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood. 2001;98(4):906-912. 11493432 10.1182/blood.V98.4.906
77. Szabo G Dolganiuc A: The role of plasmacytoid dendritic cell-derived IFN alpha in antiviral immunity. Crit Rev Immunol. 2008;28(1):61-94. 18298384 10.1615/CritRevImmunol.v28.i1.40
78. Costa-Mattioli M Sonenberg N: RAPping production of type I interferon in pDCs through mTOR. Nat Immunol. 2008;9(10):1097-1099. 18800159 10.1038/ni1008-1097
79. Cao W Manicassamy S Tang H: Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol. 2008;9(10):1157-1164. 18758466 10.1038/ni.1645 3732485
80. Corcoran SE O'Neill LA: HIF1α and metabolic reprogramming in inflammation. J Clin Invest. 2016;126(10):3699-3707. 27571407 10.1172/JCI84431 5096812
81. Van Krinks CH Matyszak MK Gaston JS: Characterization of plasmacytoid dendritic cells in inflammatory arthritis synovial fluid. Rheumatology (Oxford). 2004;43(4):453-460. 14762226 10.1093/rheumatology/keh115
82. Lande R Giacomini E Serafini B: Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J Immunol. 2004;173(4):2815-2824. 15295000 10.4049/jimmunol.173.4.2815
83. Cavanagh LL Boyce A Smith L: Rheumatoid arthritis synovium contains plasmacytoid dendritic cells. Arthritis Res Ther. 2005;7(2):R230-240. 15743469 10.1186/ar1467 1065313
84. Arimura K Takagi H Uto T: Crucial role of plasmacytoid dendritic cells in the development of acute colitis through the regulation of intestinal inflammation. Mucosal Immunol. 2017; In press. 27848952 10.1038/mi.2016.96
85. Lund JM Alexopoulou L Sato A: Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A. 2004;101(15):5598-5603. 15034168 10.1073/pnas.0400937101 397437
86. Hong C Tontonoz P: Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat Rev Drug Discov. 2014;13(6):433-444. 24833295 10.1038/nrd4280
87. Wójcicka G Jamroz-Wisniewska A Horoszewicz K: Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism. Postepy Hig Med Dosw (Online). 2007;61:736-759. 18063918
88. Kidani Y Bensinger SJ: Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity. Immunol Rev. 2012;249(1):72-83. 22889216 10.1111/j.1600-065X.2012.01153.x 4007066
89. Rakhshandehroo M Knoch B Muller M: Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010;2010; pii: 612089. 20936127 10.1155/2010/612089 2948931
90. Kiss M Czimmerer Z Nagy L: The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology. J Allergy Clin Immunol. 2013;132(2):264-286. 23905916 10.1016/j.jaci.2013.05.044
91. Horton JD Goldstein JL Brown MS: SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109(9):1125-1131. 11994399 10.1172/JCI15593 150968
92. Ikonen E: Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol. 2008;9(2):125-138. 18216769 10.1038/nrm2336
93. Oram JF Vaughan AM: ATP-Binding cassette cholesterol transporters and cardiovascular disease. Circ Res. 2006;99(10):1031-1043. 17095732 10.1161/01.RES.0000250171.54048.5c
94. Im SS Osborne TF: Liver x receptors in atherosclerosis and inflammation. Circ Res. 2011;108(8):996-1001. 21493922 10.1161/CIRCRESAHA.110.226878 3082200
95. Dove DE Linton MF Fazio S: ApoE-mediated cholesterol efflux from macrophages: separation of autocrine and paracrine effects. Am J Physiol Cell Physiol. 2005;288(3):C586-592. 15509658 10.1152/ajpcell.00210.2004
96. Hong C Duit S Jalonen P: The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2. J Biol Chem. 2010;285(26):19720-19726. 20427281 10.1074/jbc.M110.123729 2888382
97. Amuro H Ito T Miyamoto R: Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production. Arthritis Rheum. 2010;62(7):2073-2085. 20506142 10.1002/art.27478
98. Bu DX Griffin G Lichtman AH: Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol. 2011;22(3):165-170. 21412153 10.1097/MOL.0b013e3283453e41
99. Ceroi A Masson D Roggy A: LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis. Blood. 2016;128(23):2694-2707. 27702801 10.1182/blood-2016-06-724807 5271175
100. A-Gonzalez N Bensinger SJ Hong C: Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity. 2009;31(2):245-258. 19646905 10.1016/j.immuni.2009.06.018 2791787
101. York AG Williams KJ Argus JP: Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling. Cell. 2015;163(7):1716-1729. 26686653 10.1016/j.cell.2015.11.045 4783382
102. Geva-Zatorsky N Sefik E Kua L: Mining the Human Gut Microbiota for Immunomodulatory Organisms. Cell. 2017;168(5):928-943.e911. 28215708 10.1016/j.cell.2017.01.022
103. Arbez J Lamarthee B Gaugler B: Histone deacetylase inhibitor valproic acid affects plasmacytoid dendritic cells phenotype and function. Immunobiology. 2014;219(8):637-643. 24742998 10.1016/j.imbio.2014.03.013
104. Cubillos-Ruiz JR Bettigole SE Glimcher LH: Molecular Pathways: Immunosuppressive Roles of IRE1α-XBP1 Signaling in Dendritic Cells of the Tumor Microenvironment. Clin Cancer Res. 2016;22(9):2121-2126. 26979393 10.1158/1078-0432.CCR-15-1570 4854763
105. Hirai M Kadowaki N Kitawaki T: Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis. Blood. 2011;117(2):500-509. 20956804 10.1182/blood-2010-05-284737